openPR Logo
Press release

Bulimia Nervosa Market : Top Key Players are Siemens Healthcare GmbH (Germany), Philips Healthcare (U.S), Abbott (U.S), Johnson & Johnson Services, Inc.(U.S), Stryker (U.S), General Electric Company

02-15-2018 09:01 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Bulimia Nervosa Market : Top Key Players are Siemens Healthcare

Bulimia nervosa is an eating disorder associated with eating a large amount of food in short time. People suffering from bulimia nervosa is increasing continuously around the globe. As eating disorders are triggered by negative energy balance accompanied by weight loss. Factors like stress, fat-shaming, nutrition education, pressure to be thin and many more are responsible causing this disorder. Diseases like diabetes and many other cardiovascular diseases are also responsible for increasing the market on bulimia nervosa. High cost of treatment is the major restraining factor for the growth of the market. Global bulimia nervosa market is expected to grow at a CAGR of 4.5% during forecasted period 2017-2023.

According to findings from the WHO in 2014, approximately 422 million people suffered from diabetes. Due to the increasing diabetic population across the globe there is a significant increase in the number of people suffering from cardiovascular diseases. Additionally, increasing geriatric population and increasing healthcare expenditure have fuelled the growth of the market.

Get a sample report at https://www.marketresearchfuture.com/sample_request/1417 .

Global Bulimia Nervosa Market - Competitive Analysis

Siemens Healthcare GmbH (Germany), Philips Healthcare (U.S), Abbott (U.S), Johnson & Johnson Services, Inc.(U.S), Stryker (U.S), General Electric Company (U.K), Covidien ltd (Ireland), AstraZeneca (U.K) Penumbra, Inc. (U.S) are some of the prominent players at the forefront of competition in the Global Bulimia Nervosa Market and are profiled in MRFR Analysis.

Due to increasing prevalence of bulimia nervosa across the globe many of the companies are in the race to introduce better treatment for bulimia nervosa. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market.

AstraZeneca is a multinational pharmaceutical and biopharmaceutical company headquartered in UK. Recently AstraZeneca has completed its collaboration with National Institute of Mental Health. This collaboration will help to discover the new and better drug treatment for distressing condition. AstraZeneca has also collaborated with Vanderbilt Center for the Neuroscience Drug Discovery which aims to discover new drug for the treatment of neuropsychiatric disorders.

According to the World Health Organization (WHO), in 2015, over 17.7 million people died from cardiovascular diseases, representing 31% of all global deaths. According to the Centers for Disease Control and Prevention (2015), over 630,000 Americans died from heart disease each year, which accounted for 1 in every 4 deaths. According to findings from the WHO, in 2015, 82% of the total deaths were occurred in low- and middle-income countries. Beside this, globally 39% of adults aged 18 years and over were overweight in 2016, and 13% were obese.

 Browse Complete Report at https://www.marketresearchfuture.com/reports/bulimia-nervosa-market-1417 .

Global Bulimia Nervosa Market - Regional Analysis

On regional basis, North America has the leading bulimia nervosa market due to increasing prevalence of this disorder in North America. 6.2 million People are suffering with this bulimia nervosa in North America majority of them are young adults. Beside this unmet need of medication and technological advances is the other factor for growth of this market in North America.

According to World Population Ageing Report, in 2017, there are an estimated 962 million people aged 60 or over globally, which is 13% of the total global population. According to the population reference bureau, the number of Americans ageing 65 and older is projected to more than double from 46 million in 2015 to over 98 million by 2060. According to the StastsCan, 2015, over 5.7 million Canadians have aged 65 and older, which was 16.1 % of Canadian population. According to Statistics Canada projections, this trend will only increase. By 2031, one in four Canadians will be over 65 age. According to the WHO, 2015, Asia's elderly population is projected to reach nearly 923 million by 2050. Growing geriatric is fuelling the number of patients suffering from cardiovascular diseases owing to the high susceptibility of this population pool to developing cardiovascular diseases. Increasing geriatric population will increase the market for cardiovascular devices since they are more vulnerable towards cardiovascular diseases such as hypertension, stroke, and other diseases. Moreover, increasing healthcare expenditure has provided fuel for the growth of the market.

North America is followed by Europe in bulimia nervosa market. Increasing number of diabetic population, patents suffering from other cardiovascular diseases, technological advances and well developed healthcare sector has led to grow this market in Europe. Asia Pacific is the fastest growing market due to a huge population base and increasing prevalence of diabetes and other bulimia nervosa causing disease. The Middle East & Africa has the least market for bulimia nervosa.

 About us

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

P: +1 646 845 9312

W: www.marketresearchfuture.com

sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bulimia Nervosa Market : Top Key Players are Siemens Healthcare GmbH (Germany), Philips Healthcare (U.S), Abbott (U.S), Johnson & Johnson Services, Inc.(U.S), Stryker (U.S), General Electric Company here

News-ID: 944361 • Views:

More Releases from Market Research Future

Global Small Boat Industry Sees Growing Demand Amid Rising Recreational Boating and Coastal Activities
Global Small Boat Industry Sees Growing Demand Amid Rising Recreational Boating …
As per the latest analysis by Market Research Future, the Small Boats Market Size was estimated at 17.12 (USD Billion) in 2024. The Small Boats Market Industry is expected to grow from 17.88 (USD Billion) in 2025 to 26.41 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 4.43% during the forecast period (2025 - 2034). The global small boat industry is witnessing significant growth, driven
Automotive Trim Market Attaining USD 193.22 Billion till 2034 | Innovations Redefine Vehicle Aesthetics and Functionality
Automotive Trim Market Attaining USD 193.22 Billion till 2034 | Innovations Rede …
As per the latest analysis by Market Research Future, the Automotive Trim Market Size was estimated at 140.30 (USD Billion) in 2024. The Automotive Trim Market Industry is expected to grow from 144.87 (USD Billion) in 2025 to 193.22 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 3.25% during the forecast period (2025 - 2034). The automotive industry is witnessing a significant transformation in vehicle
Leading Automotive Technology Firms Expand Fuel Level Sensor Solutions for Next-Generation Vehicles | Robert Bosch Gmbh, Technoton
Leading Automotive Technology Firms Expand Fuel Level Sensor Solutions for Next- …
As per the latest analysis by Market Research Future, Automotive Fuel Level Sensor Market Size was valued at USD 5,788.04 million in 2024. The Automotive Fuel Level Sensor market industry is projected to grow from USD 6,008.32 million in 2025 to USD 9,201.90 million by 2035, exhibiting a compound annual growth rate (CAGR) of 4.35% during the forecast period (2024 - 2035). With the global automotive industry focused on precision,
Valet Parking Technology Gains Momentum as Urban Mobility and Smart Infrastructure Evolve | Market Growth with 15.62% CAGR
Valet Parking Technology Gains Momentum as Urban Mobility and Smart Infrastructu …
As per the latest analysis by Market Research Future, the Valet Parking Technology Market Size was estimated at 1.41 (USD Billion) in 2024. The Valet Parking Technology Market Industry is expected to grow from 1.63 (USD Billion) in 2025 to 6.01 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 15.62% during the forecast period (2025 - 2034). Valet parking technology is emerging as a transformative

All 5 Releases


More Releases for Bulimia

Bulimia Nervosa Market Overview: Global Size, Share, Analysis, and Forecast till …
" The Bulimia Nervosa market addresses a critical area within the broader mental health landscape, focused on the diagnosis, treatment, and management of this serious eating disorder. The market's growth is propelled by increasing awareness of mental health issues globally, advancements in therapeutic interventions, and a growing emphasis on early diagnosis and intervention. Technological advancements, particularly in telehealth and digital therapeutics, are expanding access to care, especially in underserved communities. The
Bulimia Nervosa Treatment Market 2024: Trends, Developments Factors, Competitive …
The Latest study titled Bulimia Nervosa Treatment Market 2024, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2024 to 2031. The comprehensive research delves into the evolving market dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. Additionally, the
Bulimia Nervosa Market Size to touch USD 1.5 billion by the end of 2032
The global demand for the Bulimia Nervosa market is projected to reach approximately USD 1.5 billion by 2032, up from USD 0.77 billion in 2023, reflecting a robust CAGR of 7.78% over the forecast period from 2024 to 2032. This growth is driven by increasing awareness of eating disorders, advancements in diagnostic and therapeutic approaches, and the rising prevalence of bulimia nervosa. Industry trends indicate a growing emphasis on personalized
Bulimia Nervosa Treatment Market Analysis Growth Opportunities and Trends by For …
Global Bulimia Nervosa Treatment Market: Overview Bulimia nervosa refers to a type of eating disorder linked with binge eating following compensatory processes. Patients suffering from bulimia nervosa come with repeated episodes of binge eating that might involve having food in large portions. This eating disorder is also known as binge eating disorder. GET A BROCHURE OF THE REPORT @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=7106 Affected individuals often eat larger portions than normal individuals under similar circumstances and
Bulimia Nervosa Treatment Market to Register Unwavering Growth During 2030
Global Bulimia Nervosa Treatment Market: Overview Bulimia nervosa refers to a type of eating disorder linked with binge eating following compensatory processes. Patients suffering from bulimia nervosa come with repeated episodes of binge eating that might involve having food in large portions. This eating disorder is also known as binge eating disorder. Affected individuals often eat larger portions than normal individuals under similar circumstances and same duration do. These patients often
Bulimia Nervosa Treatment Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Bulimia Nervosa Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Bulimia Nervosa Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.